Rhumbline Advisers Liquidia Corp Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Liquidia Corp stock. As of the latest transaction made, Rhumbline Advisers holds 77,911 shares of LQDA stock, worth $829,752. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,911

Previous 80,164 2.81%

Holding current value

$829,752

Previous $961,000 18.94%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$8.9 - $14.11 $20,051 - $31,789	-2,253 Reduced 2.81%	77,911 $779,000
Q2 2024 Aug 01, 2024	BUY	$11.96 - $15.71 $106,097 - $139,363	8,871 Added 12.44%	80,164 $961,000
Q1 2024 May 09, 2024	BUY	$11.35 - $16.73 $10,918 - $16,094	962 Added 1.37%	71,293 $1.05 Million
Q4 2023 Feb 08, 2024	SELL	$5.77 - $12.19 $3,352 - $7,082	-581 Reduced 0.82%	70,331 $846,000
Q3 2023 Nov 09, 2023	SELL	$6.27 - $8.15 $2,827 - $3,675	-451 Reduced 0.63%	70,912 $449,000
Q2 2023 Aug 08, 2023	BUY	$6.63 - $9.9 $22,734 - $33,947	3,429 Added 5.05%	71,363 $560,000
Q1 2023 May 11, 2023	BUY	$5.72 - $7.91 $26,209 - $36,243	4,582 Added 7.23%	67,934 $469,000
Q4 2022 Feb 14, 2023	SELL	$4.68 - $6.54 $4,300 - $6,010	-919 Reduced 1.43%	63,352 $404,000
Q3 2022 Nov 10, 2022	BUY	$3.73 - $8.39 $15,785 - $35,506	4,232 Added 7.05%	64,271 $350,000
Q2 2022 Aug 11, 2022	BUY	$3.37 - $7.55 $202,331 - $453,294	60,039 New	60,039 $262,000
Q2 2021 Aug 05, 2021	SELL	$2.51 - $3.11 $54,241 - $67,207	-21,610 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$2.42 - $3.6 $242 - $360	100 Added 0.46%	21,610 $58,000
Q4 2020 Feb 10, 2021	BUY	$2.6 - $5.79 $7,254 - $16,154	2,790 Added 14.9%	21,510 $63,000
Q3 2020 Nov 12, 2020	SELL	$4.34 - $8.28 $7,161 - $13,661	-1,650 Reduced 8.1%	18,720 $92,000
Q2 2020 Aug 13, 2020	BUY	$4.86 - $11.44 $33,359 - $78,524	6,864 Added 50.82%	20,370 $172,000
Q4 2019 Feb 05, 2020	BUY	$3.07 - $5.11 $325 - $541	106 Added 0.79%	13,506 $58,000
Q3 2019 Oct 23, 2019	SELL	$3.29 - $8.24 $411 - $1,030	-125 Reduced 0.92%	13,400 $48,000
Q2 2019 Aug 14, 2019	BUY	$7.92 - $11.39 $107,118 - $154,049	13,525 New	13,525 $108,000

Others Institutions Holding LQDA

# of Institutions

171

Shares Held

44.3M

Call Options Held

1.55M

Put Options Held

1.52M

View Full List

About Liquidia Corp

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $685M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

More about LQDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Liquidia Corp Transaction History